Meta Platforms, Inc.
Meta Platforms, Inc. (META) Financial Performance & Income Statement Overview
Analyze Meta Platforms, Inc. (META) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Meta Platforms, Inc. (META) Income Statement & Financial Overview
View the income breakdown for Meta Platforms, Inc. META across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $42.31B | $48.38B | $40.59B | $39.07B |
| Cost of Revenue | $7.57B | $8.84B | $7.38B | $7.31B |
| Gross Profit | $34.74B | $39.55B | $33.21B | $31.76B |
| Gross Profit Ratio | $0.82 | $0.82 | $0.82 | $0.81 |
| R&D Expenses | $12.15B | $12.18B | $11.18B | $10.54B |
| SG&A Expenses | $5.04B | $4.002B | $4.69B | $6.38B |
| Operating Expenses | $17.19B | $16.18B | $15.86B | $16.92B |
| Total Costs & Expenses | $24.76B | $25.02B | $23.24B | $24.22B |
| Interest Income | $658.00M | $731.00M | $661.00M | $540.00M |
| Interest Expense | $240.00M | $251.00M | $208.00M | $128.00M |
| Depreciation & Amortization | $3.90B | $4.46B | $4.03B | $3.64B |
| EBITDA | $22.52B | $28.26B | $22.06B | $18.87B |
| EBITDA Ratio | $0.53 | $0.58 | $0.54 | $0.48 |
| Operating Income | $17.55B | $23.36B | $17.35B | $14.85B |
| Operating Income Ratio | $0.41 | $0.48 | $0.43 | $0.38 |
| Other Income/Expenses (Net) | $827.00M | $188.00M | $472.00M | $259.00M |
| Income Before Tax | $18.38B | $23.55B | $17.82B | $15.11B |
| Income Before Tax Ratio | $0.43 | $0.49 | $0.44 | $0.39 |
| Income Tax Expense | $1.74B | $2.71B | $2.13B | $1.64B |
| Net Income | $16.64B | $20.84B | $15.69B | $13.46B |
| Net Income Ratio | $0.39 | $0.43 | $0.39 | $0.34 |
| EPS | $6.59 | $8.22 | $6.20 | $5.31 |
| Diluted EPS | $6.43 | $8.02 | $6.03 | $5.16 |
| Weighted Avg Shares Outstanding | $2.53B | $2.53B | $2.53B | $2.53B |
| Weighted Avg Shares Outstanding (Diluted) | $2.59B | $2.61B | $2.60B | $2.61B |
Over the past four quarters, Meta Platforms, Inc. demonstrated steady revenue growth, increasing from $39.07B in Q2 2024 to $42.31B in Q1 2025. Operating income reached $17.55B in Q1 2025, maintaining a consistent 41% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $22.52B, reflecting operational efficiency. Net income dropped to $16.64B, with EPS at $6.59. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan